New drug formulations tested in healthy volunteers

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Body mass index (BMI) between 18.5 kg/m2 to 32.0 kg/m2 (inclusive) * Females of childbearing potential agree to take appropriate measures to prevent pregnancy during the study * Males who do not have a documented vasectomy or are not congenitally sterile must agree to abstinence or use of barrier method with spermicide with female partner. Male participant who is having sexual intercourse with a woman of childbearing potential who is not currently pregnant will be advised of her requirement to use an additional highly effective contraceptive method * NOTE - Additional criteria apply, please contact the investigator for more information Exclusion Criteria: * Participation in another clinical trial simultaneously * Females who are lactating, breastfeeding, or intends to become pregnant over the course of the study * History of alcohol, drug or any other substance, abuse, addiction or dependence in the last 12 months (except for caffeine) * Major trauma or surgery in the 2 months before screening or at any time between screening and the first dose of IMP, or surgery scheduled during the study or follow-up period * Donated blood or blood products (eg, white blood cells \[WBCs\], platelets, etc.) within the 60 days before screening, or has donated blood or blood products at least twice within the 6 months before screening, or has donated plasma within 7 days of the screening visit or has received blood or blood products in the 6 weeks before screening * Personal or family history of arrhythmia, sudden unexplained death at a young age (before 40 years) in a first-degree relative, or long QT syndrome, or a personal history of syncope, or previous personal treatment for high blood pressure * NOTE - Additional criteria apply, please contact the investigator for more information